BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Head and neck cancer AND CTLA4, ALPS5, CD, CD152, CELIAC3, CTLA-4, GRD4, GSE, IDDM12 AND Diagnosis
144 results:

  • 1. Clear cell oral squamous cell carcinoma as a diagnostic conundrum: report of 2 rare cases.
    Sharma K; Chauhan A; Sharma P; Wadhwan V; Tyagi S; Sharma R
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2024 May; 137(5):e83-e90. PubMed ID: 38281881
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Development and validation of glycosyltransferase related-gene for the diagnosis and prognosis of head and neck squamous cell carcinoma.
    He M; Wang L; Yue Z; Feng C; Dai G; Jiang J; Huang H; Ji Q; Zhou M; Li D; Chai W
    Aging (Albany NY); 2024 Jan; 16(2):1750-1766. PubMed ID: 38244579
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. The dynamic role of immune checkpoint molecules in diagnosis, prognosis, and treatment of head and neck cancers.
    Mestiri S; El-Ella DMA; Fernandes Q; Bedhiafi T; Almoghrabi S; Akbar S; Inchakalody V; Assami L; Anwar S; Uddin S; Gul ARZ; Al-Muftah M; Merhi M; Raza A; Dermime S
    Biomed Pharmacother; 2024 Feb; 171():116095. PubMed ID: 38183744
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Pneumatosis intestinalis in cancer patients who received immune checkpoint inhibitors.
    Sperling G; Shatila M; Varatharajalu K; Lu Y; Altan M; Zhou Y; Zhao D; De Toni EN; Török HP; Schneider BJ; Khan A; Thomas AS; Zhang HC; Shafi MA; Wang Y
    J Cancer Res Clin Oncol; 2023 Dec; 149(19):17597-17605. PubMed ID: 37917197
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Effects of abnormal expression of CD73 on malignant phenotype of nasopharyngeal carcinoma.
    Jiang B; Tang M; Shi S; Xie H; Pan S; Zhang L; Sheng J
    J Mol Histol; 2023 Dec; 54(6):633-644. PubMed ID: 37874500
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Noninvasive radiomic analysis of enhanced CT predicts ctla4 expression and prognosis in head and neck squamous cell carcinoma.
    Zhu Y; Wu M
    Sci Rep; 2023 Oct; 13(1):16782. PubMed ID: 37798374
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Neoadjuvant PD-1/PD-L1 axis blockade for patients with head and neck squamous cell carcinoma.
    Huang S; Xiong C; Tan K
    Am J Otolaryngol; 2023; 44(6):103985. PubMed ID: 37442083
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. An immune checkpoint-based signature predicts prognosis and chemotherapy response for patients with small cell lung cancer.
    Wang L; Wu P; Shen Z; Yu Q; Zhang Y; Ye F; Chen K; Zhao J
    Int Immunopharmacol; 2023 Apr; 117():109827. PubMed ID: 36989973
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Lymphoepithelial carcinoma of the larynx: A clinical report with pooled analysis and review of published cases.
    Nath J; Sarma G; Das A; Das K; Kakati L
    J Cancer Res Ther; 2023 Jan; 19(Suppl 2):S466-S471. PubMed ID: 38384006
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Oral leukoplakia classification and staging system with incorporation of differentiated dysplasia.
    Brouns ER; Evren I; Wils LJ; Poell JB; Brakenhoff RH; Bloemena E; de Visscher JGAM
    Oral Dis; 2023 Oct; 29(7):2667-2676. PubMed ID: 35765231
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Morphological and immunohistochemical diagnostic of extragastrointestinal stromal tumors - a 51 case series analysis.
    Moldovan VT; Pătraşcu OM; Ali L; Costache M; Sajin M
    Rom J Morphol Embryol; 2021; 62(4):1011-1016. PubMed ID: 35673820
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Systematic Review and Meta-Analysis to Identify the Immunocytochemical Markers Effective in Delineating Benign from Malignant Thyroid Lesions in FNAC Samples.
    Mohan U; Sunny SP; Mendonca P; Kuriakose MA; Kannan S; Suresh A
    Endocr Pathol; 2022 Jun; 33(2):243-256. PubMed ID: 35596875
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Fine needle aspiration cytology of primary thyroid non-hodgkins lymphoma: Experience from a tertiary care center of North India.
    Singh M; Nain G; Jain S; Singh S; Malhotra V
    J Cancer Res Ther; 2022; 18(1):185-189. PubMed ID: 35381782
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. The prognostic and clinical significance of IFI44L aberrant downregulation in patients with oral squamous cell carcinoma.
    Ou D; Wu Y
    BMC Cancer; 2021 Dec; 21(1):1327. PubMed ID: 34903206
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Nkx3-1 and Fech genes might be switch genes involved in pituitary non-functioning adenoma invasiveness.
    Khayer N; Jalessi M; Jahanbakhshi A; Tabib Khooei A; Mirzaie M
    Sci Rep; 2021 Oct; 11(1):20943. PubMed ID: 34686726
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Associations between clinical and histopathological characteristics in oral leukoplakia.
    Evren I; Brouns ER; Poell JB; Wils LJ; Brakenhoff RH; Bloemena E; de Visscher JGAM
    Oral Dis; 2023 Mar; 29(2):696-706. PubMed ID: 34601770
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Adrenal biopsy, as a diagnostic method, is associated with decreased overall survival in patients with T1/T2 adrenocortical carcinoma: A propensity score-matched analysis.
    Naffouje SA; Sabesan A; Hallanger-Johnson J; Kirtane K; Gonzalez RJ; Mullinax J
    J Surg Oncol; 2021 Dec; 124(8):1261-1271. PubMed ID: 34424540
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Clinical Characteristics and Outcomes of Oral Mucositis Associated With Immune Checkpoint Inhibitors in Patients With cancer.
    Jacob JS; Dutra BE; Garcia-Rodriguez V; Panneerselvam K; Abraham FO; Zou F; Ma W; Grivas P; Thompson JA; Altan M; Oliva ICG; Zhang HC; Thomas AS; Wang Y
    J Natl Compr Canc Netw; 2021 Aug; 19(12):1415-1424. PubMed ID: 34348238
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Clinical value of contrast-enhanced ultrasonography in focal hypoechogenic lesions of thyroid.
    Liang S; Gao N; Bian D; Zhai Q; Yang P; Huang K
    Eur Arch Otorhinolaryngol; 2022 Apr; 279(4):2077-2082. PubMed ID: 34274997
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Clinicopathologic Features, Treatment Response, and Outcomes of Immune Checkpoint Inhibitor-Related Esophagitis.
    Panneerselvam K; Amin RN; Wei D; Tan D; Lum PJ; Zhang HC; Richards DM; Altan M; Grivas P; Thompson JA; Thomas AS; Wang Y
    J Natl Compr Canc Netw; 2021 Jun; 19(8):896-904. PubMed ID: 34102607
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 8.